Dual-Gas Eye Drops Showed Activity in Lab Cell Studies

Scientists have created a new type of eye treatment that uses light to trigger the release of two gases, which together help lower the pressure inside the eye, offering a potential new way to treat glaucoma.

A light-activated nanoparticle that releases both hydrogen and nitric oxide showed promise in cell studies for lowering intraocular pressure by improving fluid drainage from the eye through synergistic activation of cellular signaling pathways.

Researchers developed a new nanoparticle treatment for glaucoma (a disease that damages the optic nerve and causes blindness) that releases two gases—hydrogen and nitric oxide—when activated by laser light. In cell culture experiments, this dual-gas system worked by relaxing eye tissue cells and improving fluid drainage from the eye, which could lower the dangerous pressure buildup inside the eye that characterizes glaucoma.

This is early-stage research conducted only in cell cultures, not in animals or humans, so it cannot yet predict real-world effectiveness or safety in people. While the dual-gas approach is scientifically interesting, many years of additional testing would be needed before this technology could potentially become a glaucoma treatment.

Glaucoma, a leading cause of irreversible blindness worldwide, is characterized by optic nerve damage often associated with elevated intraocular pressure (IOP). Although gas therapies hold promise for glaucoma treatment, the limitations of single-gas strategies constrain their therapeutic efficacy…

Read the full abstract on PubMed